Intraocular Lens (IOL) - Medical Devices Pipeline Assessment, 2017 #1342840 $4000 246 pages In Stock Report Description Intraocular Lens (IOL) - Medical Devices Pipeline Assessment, 2017 Summary GlobalData's Medical Devices sector report, Intraocular Lens (IOL) - Medical Devices Pipeline Assessment, 2017" provides an overview of Intraocular Lens (IOL) currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Intraocular Lens (IOL) pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. Scope - Extensive coverage of the Intraocular Lens (IOL) under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Intraocular Lens (IOL) and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to 1 / 14
Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Reasons to buy The report enables you to - - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of Intraocular Lens (IOL) under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the products current stage of development, territory and estimated launch date Table Of Content Notes: 1 1 2 1.1 List of Tables 6 1.2 List of Figures 13 2 Introduction 14 2.1 Intraocular Lens (IOL) Overview 14 3 Products under Development 15 3.1 Intraocular Lens (IOL) - Pipeline Products by Stage of Development 15 3.2 Intraocular Lens (IOL) - Pipeline Products by Segment 16 3.3 Intraocular Lens (IOL) - Pipeline Products by Territory 17 3.4 Intraocular Lens (IOL) - Pipeline Products by Regulatory Path 18 3.5 Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date 19 3.6 Intraocular Lens (IOL) - Ongoing Clinical Trials 20 4 Intraocular Lens (IOL) - Pipeline Products under Development by Companies 21 4.1 Intraocular Lens (IOL) Companies - Pipeline Products by Stage of Development 21 4.2 Intraocular Lens (IOL) - Pipeline Products by Stage of Development 23 2 / 14
5 Intraocular Lens (IOL) Companies and Product Overview 28 5.1 Abbott Medical Optics Inc Company Overview 28 5.1.1 Abbott Medical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 28 5.2 Adoptics AG (Inactive) Company Overview 30 5.2.1 Adoptics AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30 5.3 AkkoLens International BV Company Overview 31 5.3.1 AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview 31 5.4 Alcon Laboratories Inc Company Overview 32 5.4.1 Alcon Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 32 5.5 Anew Optics, Inc. Company Overview 41 5.5.1 Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41 5.6 Bausch & Lomb Inc Company Overview 42 5.6.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 42 5.7 Clarvista Medical, Inc. Company Overview 43 5.7.1 Clarvista Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43 5.8 Elenza, Inc. Company Overview 47 5.8.1 Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47 5.9 Emmetrope Incorporated Company Overview 48 5.9.1 Emmetrope Incorporated Pipeline Products & Ongoing Clinical Trials Overview 48 5.10 Eye4Vision Ophthalmics International Company Overview 51 5.10.1 Eye4Vision Ophthalmics International Pipeline Products & Ongoing Clinical Trials Overview 51 5.11 EyeKon Medical Inc Company Overview 52 5.11.1 EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 52 5.12 Hoya Surgical Optics Inc Company Overview 108 5.12.1 Hoya Surgical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 108 5.13 IFS Construction Services Ltd Company Overview 110 5.13.1 IFS Construction Services Ltd Pipeline Products & Ongoing Clinical Trials Overview 110 5.14 InfiniteVision Optics, SAS Company Overview 111 5.14.1 InfiniteVision Optics, SAS Pipeline Products & Ongoing Clinical Trials Overview 111 5.15 Innovia LLC Company Overview 114 5.15.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 114 5.16 LayerBio Inc Company Overview 115 5.16.1 LayerBio Inc Pipeline Products & Ongoing Clinical Trials Overview 115 5.17 LensGen, Inc. Company Overview 116 3 / 14
5.17.1 LensGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 116 5.18 London Eye Hospital Pharma Company Overview 117 5.18.1 London Eye Hospital Pharma Pipeline Products & Ongoing Clinical Trials Overview 117 5.19 Meir Medical Center Company Overview 118 5.19.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview 118 5.20 Morcher Gmbh Company Overview 119 5.20.1 Morcher Gmbh Pipeline Products & Ongoing Clinical Trials Overview 119 5.21 NuLens Ltd. (Inactive) Company Overview 141 5.21.1 NuLens Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 141 5.22 Ocumetics Technology Corp Company Overview 142 5.22.1 Ocumetics Technology Corp Pipeline Products & Ongoing Clinical Trials Overview 142 5.23 PowerVision, Inc. Company Overview 143 5.23.1 PowerVision, Inc. Pipeline Products & Ongoing Clinical Trials Overview 143 5.24 Presbeasy Company Overview 146 5.24.1 Presbeasy Pipeline Products & Ongoing Clinical Trials Overview 146 5.25 Rayner Intraocular Lenses Ltd Company Overview 147 5.25.1 Rayner Intraocular Lenses Ltd Pipeline Products & Ongoing Clinical Trials Overview 147 5.26 RxSight Inc Company Overview 162 5.26.1 RxSight Inc Pipeline Products & Ongoing Clinical Trials Overview 162 5.27 Santen Pharmaceutical Co Ltd Company Overview 163 5.27.1 Santen Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 163 5.28 Sharklet Technologies, Inc. Company Overview 164 5.28.1 Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 164 5.29 STAAR Surgical Company Company Overview 165 5.29.1 STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview 165 5.30 Strathspey Crown LLC Company Overview 170 5.30.1 Strathspey Crown LLC Pipeline Products & Ongoing Clinical Trials Overview 170 5.31 University of Rochester Company Overview 171 5.31.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 171 5.32 University of Tampere Company Overview 172 5.32.1 University of Tampere Pipeline Products & Ongoing Clinical Trials Overview 172 5.33 Valeant Pharmaceuticals International Inc Company Overview 173 5.33.1 Valeant Pharmaceuticals International Inc Pipeline Products & Ongoing Clinical Trials Overview 173 5.34 Visidome Ltd Company Overview 174 4 / 14
5.34.1 Visidome Ltd Pipeline Products & Ongoing Clinical Trials Overview 174 5.35 Visioneering Technologies Inc Company Overview 175 5.35.1 Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 175 5.36 Washington University in St Louis Company Overview 176 5.36.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 176 5.37 Xend Company Overview 177 5.37.1 Xend Pipeline Products & Ongoing Clinical Trials Overview 177 5.38 Z Lens LLC Company Overview 178 5.38.1 Z Lens LLC Pipeline Products & Ongoing Clinical Trials Overview 178 6 Intraocular Lens (IOL)- Recent Developments 179 6.1 Sep 18, 2017: Abbott and the Abbott Fund Expand Support for Hurricane Relief With $1 Million to Help Families Affected by Hurricane Irma 179 6.2 Sep 15, 2017: Swiss Advanced Vision Announces Launch of New Intraocular Lens, LUCIDIS 179 6.3 Sep 15, 2017: Swiss Advanced Vision Announces Launch of New Intraocular Lens, EDEN 180 6.4 Sep 15, 2017: Valeant Commits $200,000 to Support Hurricane Relief Efforts 180 6.5 Sep 07, 2017: Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index 180 6.6 Sep 07, 2017: Industry Leader Dr. Doug Benoit Joins VTI as Executive Director of Professional Affairs 181 6.7 Aug 15, 2017: World's fastest growing IOL Company - Opens Second Manufacturing Facility in Thailand 182 6.8 Aug 08, 2017: Valeant Announces Second-Quarter 2017 Results 182 6.9 Aug 02, 2017: STAAR Surgical Reports Second Quarter 2017 Results 185 6.10 Aug 01, 2017: Visioneering Technologies Announces Lynn Cali-Cianci As Executive Territory Manager, New York City/Long Island 186 6.11 Jul 27, 2017: Hoya Reports First Quarter Financial Results 187 6.12 Jul 25, 2017: Visioneering Technologies Appoints Lisa Humble as Senior Territory Manager For North and South Carolina 187 6.13 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 188 6.14 Jul 20, 2017: Dr. Jim Raulino Joins the VTI Team as Executive Territory Manager for Sacramento and Reno 190 6.15 Jul 13, 2017: Visioneering Technologies Appoints Michelle Kirst as Territory Manager for New Jersey 190 6.16 Jul 11, 2017: Visioneering Technologies Appoints Ron Makelke as Territory Manager for San Francisco 191 6.17 Jul 06, 2017: Visioneering Technologies Appoints Carol Baez as Executive Territory Manager for Orange County/San Diego 191 6.18 Jun 27, 2017: Visioneering Technologies Names Mark Rapoport as New CFO 192 5 / 14
6.19 Jun 22, 2017: Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International 192 6.20 Jun 19, 2017: Valeant Appoints Arthur J. Shannon As Senior Vice President, Head Of Investor Relations And Communications 193 6.21 Jun 19, 2017: John Paulson Joins Valeant Board Of Directors 193 6.22 Jun 14, 2017: The Eye Institute of Utah Now Offering FDA-Approved Acrysof IQ ReSTOR +2.5 Multifocal Toric IOL with ACTIVEFOCUS for Cataract Surgery 193 6.23 May 30, 2017: The German Court has Granted a Preliminary Injunction in Favour of VSY Biotechnology BV and Against Carl Zeiss Meditec 194 6.24 May 11, 2017: STAAR Surgical Announces CE Mark Approval for the EVO+ Visian ICL with Aspheric (EDOF) Optic 195 6.25 May 11, 2017: Hoya Reports Fourth Quarter and Full-Year Financial Results 195 6.26 May 10, 2017: Carl Zeiss Meditec accelerates growth in the first six months of 2016/17 196 6.27 May 10, 2017: Santen Reports Fiscal 2016 Consolidated Performance 197 6.28 May 09, 2017: Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range 197 6.29 May 08, 2017: ZEISS Appoints New Fellow 198 6.30 May 08, 2017: Systemic therapy outperforms intraocular implant for treating uveitis 199 6.31 May 05, 2017: Valeant Announces Key Appointments In Dermatology And Corporate Communications Leadership 200 6.32 May 03, 2017: Las Vegas Cataract Surgeon Says the TECNIS Symfony Intraocular Lens Offers Patients an Excellent New Lifestyle Option 201 6.33 May 03, 2017: Alcon launches newly approved Multifocal Toric IOL with ACTIVEFOCUS optical design, highlights other surgical innovations at the American Society of Cataract and Refractive Surgery 2017 annual meeting 202 6.34 May 03, 2017: STAAR Surgical Reports First Quarter 2017 Results 205 6.35 Apr 25, 2017: ZEISS Opens New Microscopy Customer Center 206 6.36 Apr 19, 2017: Abbott Reports First-Quarter 2017 Results 206 6.37 Apr 05, 2017: STAAR Surgical Names Deborah Andrews Interim CFO 209 6.38 Apr 04, 2017: Carl Zeiss Meditec Group achieves first half 2016/17 revenue of approximately EUR 588 million 209 6.39 Mar 27, 2017: Carl Zeiss Meditec wins patent infringement action on trifocal intraocular lens against VSY Biotechnology and Fritz Ruck Ophthalmologische Systeme 210 6.40 Mar 23, 2017: Alcon Receives US FDA Approval For New AcrySof IQ ReSTOR +2.5 Multifocal Toric IOL 6 / 14
With ACTIVEFOCUS Design For Uncompromised Distance Vision And Presbyopia Correction 210 6.41 Mar 22, 2017: ClarVista Medical Completes Important Milestone to Advance Novel Modular Intraocular Lens for Cataract Lens Replacement 211 6.42 Mar 15, 2017: Santen Pharmaceutical: Notice of Corporate Officer Appointments 211 6.43 Mar 02, 2017: STAAR Surgical Reports Fourth Quarter 2016 Results 213 6.44 Feb 28, 2017: Valeant Reports Fourth Quarter And Full Year 2016 Financial Results And Provides 2017 Guidance 214 6.45 Feb 23, 2017: Calhoun Vision Becomes RxSight 218 6.46 Feb 10, 2017: Carl Zeiss Meditec Off to A Solid Start Into Business Year 2016/17 219 6.47 Feb 07, 2017: Santen Pharma Reports Revenue Of JPY150.7 Billion In Nine Months Ended December 31, 2016 220 6.48 Jan 31, 2017: Hoya Announces Third Quarter Financial Results 220 6.49 Jan 26, 2017: Alcon launches new trifocal toric intraocular lens for patients with astigmatism undergoing cataract surgery 220 6.50 Jan 17, 2017: Visioneering Technologies Announces Jeff Babbe as New Executive Territory Manager for Chicago, IL 221 6.51 Jan 04, 2017: Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its Board Of Directors 222 6.52 Dec 23, 2016: Alcon receives US FDA approval for AcrySof IQ ReSTOR +3.0D Multifocal Toric intraocular lens for cataract patients 222 6.53 Dec 21, 2016: Visioneering Technologies Announces Brian Atkinson as Territory Manager for the Dallas/Ft. Worth Market 223 6.54 Dec 13, 2016: Visioneering Technologies Announces Ken Gold as New Executive Territory Manager for the Baltimore-Washington, DC Area 223 6.55 Dec 12, 2016: Valeant Appoints William D. Humphries As EVP, Dermatology 224 6.56 Dec 09, 2016: Carl Zeiss Meditec continues its growth trend 224 6.57 Dec 07, 2016: VTI names executive director of manufacturing and engineering 225 6.58 Dec 07, 2016: Visioneering Technologies Announces Ms. Rosa Lee as New Executive Director of Manufacturing & Engineering 226 6.59 Nov 17, 2016: Former Valeant Executive And Former Philidor Ceo Charged In Manhattan Federal Court For Illegal Fraud And Kickback Scheme 226 6.60 Nov 16, 2016: Center For Sight Offers Las Vegas Cataract Patients New Extended Depth of Focus Lens Implants for Reduced Dependence on Glasses 228 6.61 Nov 09, 2016: Redding Eye Surgeon Announces Arrival of FDA-Approved TECNIS Symfony Intraocular 7 / 14
Lenses 229 6.62 Nov 08, 2016: Valeant Reports Third Quarter 2016 Financial Results 230 6.63 Nov 03, 2016: STAAR Surgical Reports Third Quarter 2016 Results 233 6.64 Nov 02, 2016: Santen Consolidated Results for Q2 Fiscal 2016 234 6.65 Oct 28, 2016: Hoya Reports Second Quarter Results 235 6.66 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 235 6.67 Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer 238 6.68 Oct 12, 2016: Bausch + Lomb Booth to Feature Wet Lab During the Annual Meeting of the American Academy of Ophthalmology in Chicago 239 6.69 Oct 06, 2016: Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer 241 6.70 Oct 03, 2016: Santen: Personnel Changes of Corporate Officer 242 7 Appendix 243 7.1 Methodology 243 7.2 About GlobalData 246 7.3 Contact Us 246 7.4 Disclaimer 246 1.1 List of Tables Table 1: Intraocular Lens (IOL) - Pipeline Products by Stage of Development 15 Table 2: Intraocular Lens (IOL) - Pipeline Products by Segment 16 Table 3: Intraocular Lens (IOL) - Pipeline Products by Territory 17 Table 4: Intraocular Lens (IOL) - Pipeline Products by Regulatory Path 18 Table 5: Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date 19 Table 6: Intraocular Lens (IOL) - Ongoing Clinical Trials 20 Table 7: Intraocular Lens (IOL) Companies - Pipeline Products by Stage of Development 21 Table 8: Intraocular Lens (IOL) - Pipeline Products by Stage of Development 23 Table 9: Abbott Medical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 28 Table 10: Intraocular Lens - Astigmatism - Product Status 28 Table 11: Intraocular Lens - Astigmatism - Product Description 28 Table 12: Intraocular Lens - Presbyopia - Product Status 29 Table 13: Intraocular Lens - Presbyopia - Product Description 29 Table 14: Adoptics AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30 Table 15: Shape-Changing Accommodating Intraocular Lens - Product Status 30 Table 16: Shape-Changing Accommodating Intraocular Lens - Product Description 30 8 / 14
Table 17: AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview 31 Table 18: AkkoLens AIOL - Product Status 31 Table 19: AkkoLens AIOL - Product Description 31 Table 20: Alcon Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 32 Table 21: Accommodative Intraocular Lens - Product Status 32 Table 22: Accommodative Intraocular Lens - Product Description 33 Table 23: AcrySof Cachet Angle-Supported Phakic Lens - Product Status 33 Table 24: AcrySof Cachet Angle-Supported Phakic Lens - Product Description 33 Table 25: AcrySof IQ PanOptix Toric IOL - Product Status 34 Table 26: AcrySof IQ PanOptix Toric IOL - Product Description 34 Table 27: Acrysof IQ Restor +8 Multifocal Intraocular Lens - Product Status 34 Table 28: Acrysof IQ Restor +8 Multifocal Intraocular Lens - Product Description 35 Table 29: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Status 35 Table 30: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Description 35 Table 31: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Status 35 Table 32: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Description 36 Table 33: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Status 36 Table 34: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Description 36 Table 35: AcrySof IQ Toric Diopter Range Expansion - Product Status 36 Table 36: AcrySof IQ Toric Diopter Range Expansion - Product Description 37 Table 37: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Status 37 Table 38: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Description 37 Table 39: Intrepid IOL - Product Status 38 Table 40: Intrepid IOL - Product Description 38 Table 41: Alcon Laboratories Inc - Ongoing Clinical Trials Overview 39 Table 42: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Patient-reported Satisfaction and Spectacle Independence with the ReSTOR 2.5 Combined with the ReSTOR 3.0 IOL in Cataract Surgery 40 Table 43: Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41 Table 44: Zephyr Lens - Product Status 41 Table 45: Zephyr Lens - Product Description 41 Table 46: Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 42 Table 47: Sarfarazi Elliptical Accommodating IOL - Product Status 42 Table 48: Sarfarazi Elliptical Accommodating IOL - Product Description 42 Table 49: Clarvista Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43 9 / 14
Table 50: HARMONI Modular IOL - Product Status 43 Table 51: HARMONI Modular IOL - Product Description 43 Table 52: Second Generation HARMONI System - Product Status 44 Table 53: Second Generation HARMONI System - Product Description 44 Table 54: Clarvista Medical, Inc. - Ongoing Clinical Trials Overview 45 Table 55: HARMONI Modular IOL - Feasibility of HARMONI Modular IOL in Restoration of Vision of Patients after Cataract Surgery 46 Table 56: Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47 Table 57: Sapphire Autofocal IOL - Product Status 47 Table 58: Sapphire Autofocal IOL - Product Description 47 Table 59: Emmetrope Incorporated Pipeline Products & Ongoing Clinical Trials Overview 48 Table 60: ActaLens - Product Status 48 Table 61: ActaLens - Product Description 48 Table 62: ActaLens-Duo - Product Status 49 Table 63: ActaLens-Duo - Product Description 49 Table 64: ActaLens-SC - Product Status 49 Table 65: ActaLens-SC - Product Description 50 Table 66: Eye4Vision Ophthalmics International Pipeline Products & Ongoing Clinical Trials Overview 51 Table 67: HYDROPHOBICx - Product Status 51 Table 68: HYDROPHOBICx - Product Description 51 Table 69: EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 52 Table 70: ACUITY FA55A-4NY IOL - Product Status 54 Table 71: ACUITY FA55A-4NY IOL - Product Description 54 Table 72: Acuity FA55A-4UV IOL - Product Status 54 Table 73: Acuity FA55A-4UV IOL - Product Description 55 Table 74: Acuity FB25B - UV IOL - Product Status 55 Table 75: Acuity FB25B - UV IOL - Product Description 55 Table 76: Acuity FB25B-NY IOL - Product Status 56 Table 77: Acuity FB25B-NY IOL - Product Description 56 Table 78: Acuity FS25B-NY IOL - Product Status 56 Table 79: Acuity FS25B-NY IOL - Product Description 57 Table 80: Acuity FS25B-UV IOL - Product Status 57 Table 81: Acuity FS25B-UV IOL - Product Description 57 Table 82: Acuity FS60S - 4NY IOL - Product Status 58 10 / 14
Table 83: Acuity FS60S - 4NY IOL - Product Description 58 Table 84: Acuity FS60S - 4UV IOL - Product Status 58 Table 85: Acuity FS60S - 4UV IOL - Product Description 59 Table 86: Acuity TN60-2NY IOL - Product Status 59 Table 87: Acuity TN60-2NY IOL - Product Description 59 Table 88: Acuity TN60-OUV IOL - Product Status 60 Table 89: Acuity TN60-OUV IOL - Product Description 60 Table 90: Acurus AB60 - OUV IOL - Product Status 60 Table 91: Acurus AB60 - OUV IOL - Product Description 61 Table 92: Acurus AY60 - OUV IOL - Product Status 61 Table 93: Acurus AY60 - OUV IOL - Product Description 61 Table 94: AQ204 Natural Clear IOL - Product Status 62 Table 95: AQ204 Natural Clear IOL - Product Description 62 Table 96: Cirrus CB60-OUV IOL - Product Status 62 Table 97: Cirrus CB60-OUV IOL - Product Description 63 Table 98: Cirrus CN60-2NY IOL - Product Status 63 Table 99: Cirrus CN60-2NY IOL - Product Description 63 Table 100: Cirrus CN60-OUV IOL - Product Status 64 Table 101: Cirrus CN60-OUV IOL - Product Description 64 Table 102: Cirrus CS25B-1 IOL - Product Status 64 Table 103: Cirrus CS25B-1 IOL - Product Description 65 Table 104: Cirrus CS25B-NY IOL - Product Status 65 Table 105: Cirrus CS25B-NY IOL - Product Description 65 Table 106: Cirrus CS60S-4 IOL - Product Status 66 Table 107: Cirrus CS60S-4 IOL - Product Description 66 Table 108: Cirrus CS60S-4NY IOL - Product Status 66 Table 109: Cirrus CS60S-4NY IOL - Product Description 67 Table 110: Cirrus CY60-OUV IOL - Product Status 67 Table 111: Cirrus CY60-OUV IOL - Product Description 67 Table 112: DGR AS55A-4NY IOL - Product Status 68 Table 113: DGR AS55A-4NY IOL - Product Description 68 Table 114: DGR AS55A-4UV IOL - Product Status 68 Table 115: DGR AS55A-4UV IOL - Product Description 69 Table 116: DGR DB60B-OUV IOL - Product Status 69 11 / 14
Table 117: DGR DB60B-OUV IOL - Product Description 69 Table 118: DGR DN60B-2NY IOL - Product Status 70 Table 119: DGR DN60B-2NY IOL - Product Description 70 Table 120: DGR DN60B-OUV IOL - Product Status 70 Table 121: DGR DN60B-OUV IOL - Product Description 71 Table 122: DGR DY60B-OUV IOL - Product Status 71 Table 123: DGR DY60B-OUV IOL - Product Description 71 Table 124: DGR SB25B IOL - Product Status 72 Table 125: DGR SB25B IOL - Product Description 72 Table 126: DGR SB25B-NY IOL - Product Status 72 Table 127: DGR SB25B-NY IOL - Product Description 73 Table 128: DGR SC25B-ONY IOL - Product Status 73 Table 129: DGR SC25B-ONY IOL - Product Description 73 Table 130: DGR SC25B-OUV IOL - Product Status 74 Table 131: DGR SC25B-OUV IOL - Product Description 74 Table 132: DGR SP60S-4NY IOL - Product Status 74 Table 133: DGR SP60S-4NY IOL - Product Description 75 Table 134: DGR SP60S-4UV IOL - Product Status 75 Table 135: DGR SP60S-4UV IOL - Product Description 75 Table 136: DGR ZF25B-ONY IOL - Product Status 76 Table 137: DGR ZF25B-ONY IOL - Product Description 76 Table 138: DGR ZF25B-OUV IOL - Product Status 76 Table 139: DGR ZF25B-OUV IOL - Product Description 77 Table 140: Eyekon EA55A IOL - Product Status 77 Table 141: Eyekon EA55A IOL - Product Description 77 Table 142: EyeKon EA55A NY IOL - Product Status 78 Table 143: EyeKon EA55A NY IOL - Product Description 78 Table 144: Eyekon EQ624 IOL - Product Status 78 Table 145: Eyekon EQ624 IOL - Product Description 79 Table 146: Eyekon EQ624 NY IOL - Product Status 79 Table 147: Eyekon EQ624 NY IOL - Product Description 79 Table 148: Eyekon HB60-OUV IOL - Product Status 80 Table 149: Eyekon HB60-OUV IOL - Product Description 80 Table 150: EyeKon HB60BF - NY IOL - Product Status 80 12 / 14
Table 151: EyeKon HB60BF - NY IOL - Product Description 81 Table 152: EyeKon HB60BF Natural Clear IOL - Product Status 81 Table 153: EyeKon HB60BF Natural Clear IOL - Product Description 81 Table 154: EyeKon HY60 OUV IOL - Product Status 82 Table 155: EyeKon HY60 OUV IOL - Product Description 82 Table 156: Eyekon MC25B - OUV IOL - Product Status 82 Table 157: Eyekon MC25B - OUV IOL - Product Description 83 Table 158: Eyekon MC60S - 4NY IOL - Product Status 83 Table 159: Eyekon MC60S - 4NY IOL - Product Description 83 Table 160: Eyekon MC60S - 4UV IOL - Product Status 84 Table 161: Eyekon MC60S - 4UV IOL - Product Description 84 Table 162: Eyekon MN60-OUV IOL - Product Status 84 Table 163: Eyekon MN60-OUV IOL - Product Description 85 Table 164: EyeKon NY204 IOL - Product Status 85 Table 165: EyeKon NY204 IOL - Product Description 85 Table 166: Eyekon NY25-Fold IOL - Product Status 86 1.2 List of Figures Figure 1: Intraocular Lens (IOL) - Pipeline Products by Stage of Development 15 Figure 2: Intraocular Lens (IOL) - Pipeline Products by Segment 16 Figure 3: Intraocular Lens (IOL) - Pipeline Products by Territory 17 Figure 4: Intraocular Lens (IOL) - Pipeline Products by Regulatory Path 18 Figure 5: Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date 19 Figure 6: Intraocular Lens (IOL) - Ongoing Clinical Trials 20 Buy This Report Single License : $ 4000 Request sample of this report Check discount this report Go For Report https://www.marketresearchreports.biz/reports/1342840/intraocular-lens-iol-medical-devices-pipelineassessment-2017-market-research-reports 13 / 14
Powered by TCPDF (www.tcpdf.org) Office: United States State Tower, 90 State Street, Suite 700, Albany, NY 12207, United States Toll Free: 866-997-4948 (USA-Canada) Tel: +1-518-621-2074 E: sales@marketresearchreports.biz 14 / 14